Skip Nav Destination

Issue Archive

Select Year

Issue

Volume 7, Issue 4

July-August 2010

In this Issue

Ask the Hematologist
Clinical Trials Corner
Diffusion
Features
In Memoriam
Mini Review
News and Reports
President’s Column
Profiles

Ask the Hematologist

Approach to Patient with a Bladder Tumor with Severe Hematuria and a Hemoglobin Level of Eight with Associated Dyspnea

Michael H. Kroll, MD

View Articletitled, Approach to Patient with a Bladder Tumor with Severe Hematuria and a Hemoglobin Level of Eight with Associated Dyspnea

Clinical Trials Corner

Myeloproliferative Neoplasms

Charles Parker, MD, Editor-in-Chief

View Articletitled, Myeloproliferative Neoplasms

Hemophilia A

Jerald Radich, MD

View Articletitled, Hemophilia A

Hodgkin Lymphoma

Peter Johnson, MD

View Articletitled, Hodgkin Lymphoma

Diffusion

The Elusive Leukemia Stem Cell

John C. Byrd, MD

View Articletitled, The Elusive Leukemia Stem Cell

Platelets Fill the Gap in Young Hearts

Robert Flaumenhaft, MD, PhD

View Articletitled, Platelets Fill the Gap in Young Hearts

That Was Then, This Is Now

Charles Parker, MD, Editor-in-Chief

View Articletitled, That Was Then, This Is Now

Autophagy Promotion With Obatoclax Overcomes Steroid Resistance in Pediatric ALL

John C. Byrd, MD

View Articletitled, Autophagy Promotion With Obatoclax Overcomes Steroid Resistance in Pediatric ALL

Clarifying the Genetic Underpinnings of the 5q- Syndrome

Diane Krause, MD, PhD

View Articletitled, Clarifying the Genetic Underpinnings of the 5q- Syndrome

Irradiation Plus Recruitment Blockade of Bone Marrow-Derived Cells in Glioblastoma: Killing the Lernaean Hydra

Gregory M. Vercellotti, MD

View Articletitled, Irradiation Plus Recruitment Blockade of Bone Marrow-Derived Cells in Glioblastoma: Killing the Lernaean Hydra

Allogeneic Transplantation 2010: A Tale of Two Diseases

Jerald Radich, MD

View Articletitled, Allogeneic Transplantation 2010: A Tale of Two Diseases

CD20: A Moving Target?

Peter Johnson, MD

View Articletitled, CD20: A Moving Target?

Promoting the Pericyte: Modeling the Anti-Angiogenic Effects of Thalidomide in HHT

Jason Gotlib, MD, MS

View Articletitled, Promoting the Pericyte: Modeling the Anti-Angiogenic Effects of Thalidomide in HHT

New Iron Age

Nelson Chao, MD, MBA

View Articletitled, New Iron Age

Targeting CD20: Still Much to Learn

Jonathan Butchar, PhD,John C. Byrd, MD

View Articletitled, Targeting CD20: Still Much to Learn

Features

Update on Health Information Technology and Hematology: Electronic Health Record Certification

Lawrence A. Solberg, Jr., MD, PhD

View Articletitled, Update on Health Information Technology and Hematology: Electronic Health Record Certification

Perspectives on the Hematology In-Service Examination

Ramon Tiu, MD

View Articletitled, Perspectives on the Hematology In-Service Examination

In Memoriam

Obituary - Helen Margaret Ranney, MD (1920-2010)

Geraldine P. Schechter, MD,Alan N. Schechter, MD

View Articletitled, Obituary - Helen Margaret Ranney, MD (1920-2010)

Mini Review

JAK Inhibitors in Myeloproliferative Neoplasms

Ayalew Tefferi, MD

View Articletitled, JAK Inhibitors in Myeloproliferative Neoplasms

News and Reports

ASH Co-Sponsors Inaugural National Conference on Blood Disorders in Public Health and Promotes the Important Role of Hematologists

Michael DeBaun, MD, MPH

View Articletitled, ASH Co-Sponsors Inaugural National Conference on Blood Disorders in Public Health and Promotes the Important Role of Hematologists

President’s Column

Reaching Out

Hal Broxmeyer, PhD

View Articletitled, Reaching Out

Profiles

ASH Members’ “Sage Advice” Shaped His Career

Paul S. Frenette, MD

View Articletitled, ASH Members’ “Sage Advice” Shaped His Career

Cover Image

Cover Image

All Issues

Advertisement intended for health care professionals

Email alerts

Latest Issue Alert

Continuous Publishing Alert

New Journal Content Alert

Latest
Most Read

Sequencing of Therapy Matters in the Era of Autologous Chimeric Antigen Receptor T-cell Therapy

Restoring T-cell Cytotoxicity To Correct Familial Hemophagocytic Lymphohistiocytosis

Not So Benign
This Is Not Your Father’s Thrombotic Thrombocytopenic Purpura

Perspective
Procedure Skills in Hematology Training: Lost Cause or Worth Fighting For?

ASH Committees Visit Capitol Hill in Support of Funding

Advertisement intended for health care professionals

Table of Contents

Ask the Hematologist

Approach to Patient with a Bladder Tumor with Severe Hematuria and a Hemoglobin Level of Eight with Associated Dyspnea

Clinical Trials Corner

Myeloproliferative Neoplasms

Hemophilia A

Hodgkin Lymphoma

Diffusion

The Elusive Leukemia Stem Cell

Platelets Fill the Gap in Young Hearts

That Was Then, This Is Now

Autophagy Promotion With Obatoclax Overcomes Steroid Resistance in Pediatric ALL

Clarifying the Genetic Underpinnings of the 5q- Syndrome

Irradiation Plus Recruitment Blockade of Bone Marrow-Derived Cells in Glioblastoma: Killing the Lernaean Hydra

Allogeneic Transplantation 2010: A Tale of Two Diseases

CD20: A Moving Target?

Promoting the Pericyte: Modeling the Anti-Angiogenic Effects of Thalidomide in HHT

New Iron Age

Targeting CD20: Still Much to Learn

Features

Update on Health Information Technology and Hematology: Electronic Health Record Certification

Perspectives on the Hematology In-Service Examination

In Memoriam

Obituary - Helen Margaret Ranney, MD (1920-2010)

Mini Review

JAK Inhibitors in Myeloproliferative Neoplasms

News and Reports

ASH Co-Sponsors Inaugural National Conference on Blood Disorders in Public Health and Promotes the Important Role of Hematologists

President’s Column

Reaching Out

Profiles

ASH Members’ “Sage Advice” Shaped His Career

Email alerts

ASH Publications

American Society of Hematology

Issue Archive

Table of Contents

Ask the Hematologist

Clinical Trials Corner

Diffusion

Features

In Memoriam

Mini Review

News and Reports

President’s Column

Profiles

Cover Image

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only